Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil
Clinical trial NCT00796666 · TERMINATED
Trial details
- NCT number
- NCT00796666
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-03-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.